高BMI人群定制化全基因组测序NIPS的敏感性与残余风险
研究基于58 105例接受定制化NIPS(不因低FF单独失败)的患者,量化FF、非整倍体与BMI的关系,并通过模拟计算不同BMI下的分析敏感性。结果显示在所有肥胖类别中,假定无FF相关检测失败,该NIPS对13、18、21三体的分析敏感性均超过传统非整倍体筛查。
要点
- 高BMI孕妇FF降低可致NIPS失败率高达24.3%,指南建议显著肥胖者考虑其他筛查。
- 定制化NIPS不因低FF单独判失败,在所有肥胖类别中13/18/21三体分析敏感性超传统筛查。
- 结论基于假定零FF相关检测失败的模拟分析,非头对头临床比较。
核心结论
- 相对于传统非整倍体筛查,在低FF下保持高准确性且检测失败率低的定制化NIPS是高BMI女性的更优筛查选择。
研究设计与样本
- 基于58 105例接受定制化NIPS(不因低FF单独失败)患者的数据,量化FF、非整倍体与BMI关系,并通过经验模拟缩放FF与敏感性分布计算不同BMI下的预期分析敏感性。
主要发现
- 高BMI女性在cfDNA-based NIPS中FF趋于降低,检测失败率可达24.3%。
- 在所有肥胖类别中,假定零FF相关检测失败,定制化NIPS对13、18、21三体的分析敏感性均超过传统非整倍体筛查。
关键数值与推荐
- 检测失败率可达24.3%(高BMI女性接受cfDNA-based NIPS时)。
- 分析敏感性按非整倍体与BMI函数计算,例如BMI=35时的18三体敏感性,通过FF与敏感性分布缩放得出。
临床怎么用
- 对于高BMI女性,定制化NIPS因低FF下高准确性和低检测失败率,可作为优于传统非整倍体筛查的选项。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Women with high body mass index (BMI) tend to have reduced fetal fraction (FF) during cell-free DNA-based noninvasive prenatal screening (NIPS), causing test failure rates up to 24.3% and prompting guidelines that recommend aneuploidy screening other than NIPS for patients with significant obesity. Because alternatives to NIPS are only preferable if they perform better, we compared the respective sensitivities at different BMI levels of traditional aneuploidy screening and a customized whole-genome sequencing NIPS. METHOD: The relationship between FF, aneuploidy, and BMI was quantified from 58 105 patients screened with a customized NIPS that does not fail samples because of low FF alone. Expected analytical sensitivity as a function of aneuploidy and BMI (eg, trisomy 18 sensitivity when BMI = 35) was determined by scaling the BMI- and aneuploidy-specific FF distribution by the FF- and aneuploidy-specific sensitivity calculated from empirically informed simulations. RESULTS: Across all classes of obesity and assuming zero FF-related test failures, analytical sensitivity for the investigated NIPS exceeded that of traditional aneuploidy screening for trisomies 13, 18, and 21. CONCLUSION: Relative to traditional aneuploidy screening, a customized NIPS with high accuracy at low FF and a low test-failure rate is a superior screening option for women with high BMI.
引用
- Muzzey D, Goldberg JD, Haverty C, et al. Noninvasive prenatal screening for patients with high body mass index: Evaluating the impact of a customized whole genome sequencing workflow on sensitivity and residual risk. Prenat Diagn. 2019. PMID: 31697845. doi:10.1002/pd.5603
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。